Division of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonjuro, Gangnam-gu, Seoul, 06273, Korea.
Division of Endocrinology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonjuro, Gangnam-gu, Seoul, 06273, Korea.
Gastric Cancer. 2022 Jan;25(1):33-41. doi: 10.1007/s10120-021-01222-4. Epub 2021 Aug 5.
We aimed to investigate the association between the triglyceride-glucose (TyG) index and gastric carcinogenesis, including precancerous conditions such as dysplasia, atrophic gastritis, and intestinal metaplasia.
Patients who received an upper endoscopic assessment at a medical center were included. The enrolled patients were divided into four categories according to their TyG index quartile (Q). To evaluate the relationship between increase of TyG index and gastric cancer, we analyzed the patients who received a health checkup twice. Moreover, receiver-operating characteristic curve analysis was used to establish cut-off value of the TyG index for gastric cancer.
Of 127,564 enrolled patients, 43,525 (34.1%) and 186 (0.1%) were diagnosed with precancerous conditions and gastric cancer, respectively. The odds ratios (ORs) of precancerous conditions given TyG index progressively increased across quartiles: using Q1 as the reference: Q2 (OR = 1.403, P < 0.001), Q3 (OR = 1.646, P < 0.001), and Q4 (OR = 1.656, P < 0.001). The ORs of gastric cancer also increased according to the quartiles: Q2 (OR = 1.619, P = 0.045), Q3 (OR = 2.180, P = 0.004), and Q4 (OR = 2.363, P = 0.001). Moreover, the increase in TyG index between baseline and follow-up tests was more significant in gastric cancer group than in control group (P = 0.001). The optimal cut-off value for predicting gastric cancer was 9.73.
The TyG index may be a novel predictive biomarker for gastric carcinogenesis. Notably, increase in the TyG index is significantly associated with gastric cancer.
本研究旨在探讨甘油三酯-葡萄糖(TyG)指数与胃癌发生之间的关系,包括癌前病变如异型增生、萎缩性胃炎和肠化生。
纳入在医疗中心接受上消化道内镜评估的患者。根据 TyG 指数四分位(Q)将纳入患者分为四组。为评估 TyG 指数增加与胃癌的关系,我们分析了接受两次健康检查的患者。此外,采用受试者工作特征曲线分析确定 TyG 指数预测胃癌的截断值。
在纳入的 127564 名患者中,分别有 43525 名(34.1%)和 186 名(0.1%)患者被诊断为癌前病变和胃癌。给定 TyG 指数,癌前病变的优势比(OR)随四分位增加而逐渐升高:以 Q1 为参考:Q2(OR=1.403,P<0.001)、Q3(OR=1.646,P<0.001)和 Q4(OR=1.656,P<0.001)。胃癌的 OR 也根据四分位呈递增趋势:Q2(OR=1.619,P=0.045)、Q3(OR=2.180,P=0.004)和 Q4(OR=2.363,P=0.001)。此外,与对照组相比,基线和随访检测之间 TyG 指数的增加在胃癌组中更为显著(P=0.001)。预测胃癌的最佳截断值为 9.73。
TyG 指数可能是胃癌发生的一种新的预测生物标志物。值得注意的是,TyG 指数的增加与胃癌显著相关。